epha2, active Search Results


paper n a epha1 signalchem cat  (Sino Biological)
90
Sino Biological paper n a epha1 signalchem cat
Paper N A Epha1 Signalchem Cat, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha2%2C+active/EPHA2%2C+Active/pm31085175-292-11-14
Average 90 stars, based on 1 article reviews
paper n a epha1 signalchem cat - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
btn-epha2[non-activated]  (Carna Inc)
95
Carna Inc btn-epha2[non-activated]
Btn Epha2[Non Activated], supplied by Carna Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha2%2C+active/BTN-EPHA2%5Bnon-activated%5D/custom%4008-421-23n%40us10351559
Average 95 stars, based on 1 article reviews
btn-epha2[non-activated] - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
epha2 crispr activation plasmid  (Santa Cruz Biotechnology)
88
Santa Cruz Biotechnology epha2 crispr activation plasmid
ALW-II-41-27 activated Nrf2 signaling whereas inhibited NF-κB signaling in Trichinella spiralis -infected mice. The protein expressions of <t>EphA2,</t> nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B, and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control group ( P < 0.01); ∗∗ indicates a significant difference from PI-IBS group ( P < 0.01).
Epha2 Crispr Activation Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha2%2C+active/EphA2+CRISPR+Activation+Plasmid/pmc05890185-75-27-45
Average 88 stars, based on 1 article reviews
epha2 crispr activation plasmid - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier
epha2 santa cruz 4  (Santa Cruz Biotechnology)
88
Santa Cruz Biotechnology epha2 santa cruz 4
ALW-II-41-27 activated Nrf2 signaling whereas inhibited NF-κB signaling in Trichinella spiralis -infected mice. The protein expressions of <t>EphA2,</t> nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B, and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control group ( P < 0.01); ∗∗ indicates a significant difference from PI-IBS group ( P < 0.01).
Epha2 Santa Cruz 4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha2%2C+active/EphA2+Lentiviral+Activation+Particles/pmc01867162-151-195-196
Average 88 stars, based on 1 article reviews
epha2 santa cruz 4 - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier
epha2, active  (Sino Biological)
90
Sino Biological epha2, active
ALW-II-41-27 activated Nrf2 signaling whereas inhibited NF-κB signaling in Trichinella spiralis -infected mice. The protein expressions of <t>EphA2,</t> nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B, and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control group ( P < 0.01); ∗∗ indicates a significant difference from PI-IBS group ( P < 0.01).
Epha2, Active, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/epha2%2C+active/EPHA2%2C+Active/custom%40e14-11g%4031085175
Average 90 stars, based on 1 article reviews
epha2, active - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
epha2 recombinant mouse protein (without catalytic activity domain)  (Thermo Fisher)
N/A
Eph Receptor A2 (EPHA2), recombinant mouse protein is supplied as a lyophilized powder. It is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also
   Buy from Supplier
epha2 active human  (Biosynth Carbosynth)
N/A
   Buy from Supplier
human epha2 active recombinant protein c-6his tag lyophilized  (Innovative Research Inc)
N/A
Human EphA2 Recombinant Protein C-6His Tag Lyophilized from Innovative Research has been recombinantly produced in Human Cells. The protein formulation is lyophilized from a 0.2 ?m filtered solution of PBS; pH7.4. with a purity of
   Buy from Supplier
epha2 active recombinant protein n-his-gst tag  (Innovative Research Inc)
N/A
EphA2 Recombinant Protein N-His-GST Tag from Innovative Research has been recombinantly produced in Baculovirus-Insect Cells. The protein formulation is supplied as sterile 20mM Tris; 500mM NaCl; 3mM DTT; pH 8.5; 10% gly with a purity
   Buy from Supplier
mouse epha2 activation kit by crispra  (OriGene)
N/A
Epha2 CRISPRa kit CRISPR gene activation of mouse Eph receptor A2
   Buy from Supplier
human eph receptor a2 epha2 activation kit by crispra  (OriGene)
N/A
EPHA2 CRISPRa kit CRISPR gene activation of human EPH receptor A2
   Buy from Supplier
human epha2 active recombinant protein c-fc tag lyophilized  (Innovative Research Inc)
N/A
Human EphA2 Recombinant Protein C-Fc Tag Lyophilized from Innovative Research has been recombinantly produced in Human Cells. The protein formulation is lyophilized from a 0.2 ?m filtered solution of PBS; pH7.4. with a purity of
   Buy from Supplier

Image Search Results


ALW-II-41-27 activated Nrf2 signaling whereas inhibited NF-κB signaling in Trichinella spiralis -infected mice. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B, and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control group ( P < 0.01); ∗∗ indicates a significant difference from PI-IBS group ( P < 0.01).

Journal: Frontiers in Pharmacology

Article Title: A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways

doi: 10.3389/fphar.2018.00272

Figure Lengend Snippet: ALW-II-41-27 activated Nrf2 signaling whereas inhibited NF-κB signaling in Trichinella spiralis -infected mice. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B, and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control group ( P < 0.01); ∗∗ indicates a significant difference from PI-IBS group ( P < 0.01).

Article Snippet: To establish EphA2 gene overexpression cells, NCM460 cells (1 × 10 5 cells/well) were seeded in six-well plates, when 60% confluence was reached, cells were transfected with EphA2 CRISPR activation plasmid or Control CRISPR activation plasmid in antibiotic-free growth medium with UltraCruz ® Transfection Reagent (Santa Cruz, CA, United States) and incubate overnight.

Techniques: Infection, Western Blot, Control

EphA2 knock-out partially inhibited the effects of ALW-II-41-27 on LPS-treated cells. NCM460 cells were transfected to obtain clones knock-out for EphA2. Control cells and EphA2 KO cells were treated for 24 h with ALW-II-41-27 (100 ng/mL) and then treated with LPS (50 ng/mL) for 24 h. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control cells ( P < 0.01); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Journal: Frontiers in Pharmacology

Article Title: A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways

doi: 10.3389/fphar.2018.00272

Figure Lengend Snippet: EphA2 knock-out partially inhibited the effects of ALW-II-41-27 on LPS-treated cells. NCM460 cells were transfected to obtain clones knock-out for EphA2. Control cells and EphA2 KO cells were treated for 24 h with ALW-II-41-27 (100 ng/mL) and then treated with LPS (50 ng/mL) for 24 h. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control cells ( P < 0.01); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Article Snippet: To establish EphA2 gene overexpression cells, NCM460 cells (1 × 10 5 cells/well) were seeded in six-well plates, when 60% confluence was reached, cells were transfected with EphA2 CRISPR activation plasmid or Control CRISPR activation plasmid in antibiotic-free growth medium with UltraCruz ® Transfection Reagent (Santa Cruz, CA, United States) and incubate overnight.

Techniques: Knock-Out, Transfection, Clone Assay, Control, Western Blot

EphA2 overexpression abolished the effects of ALW-II-41-27 on LPS-treated cells. NCM460 cells were transfected to obtain clones overexpressing for EphA2. Control cells and EphA2 overexpressing cells were treated for 24 h with ALW-II-41-27 and then treated with LPS (50 ng/mL) for 24 h. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control cells ( P < 0.01); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Journal: Frontiers in Pharmacology

Article Title: A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways

doi: 10.3389/fphar.2018.00272

Figure Lengend Snippet: EphA2 overexpression abolished the effects of ALW-II-41-27 on LPS-treated cells. NCM460 cells were transfected to obtain clones overexpressing for EphA2. Control cells and EphA2 overexpressing cells were treated for 24 h with ALW-II-41-27 and then treated with LPS (50 ng/mL) for 24 h. The protein expressions of EphA2, nuclear Nrf2, cytosol Nrf2, and nuclear NF-κB/p65, cytosol NF-κB/p65, Lamin B and β-actin in colon tissue lysates were measured by western blotting and densitometry analysis. The results are expressed as the mean ± SD ( n = 10 per group); ## indicates a significant difference from control cells ( P < 0.01); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Article Snippet: To establish EphA2 gene overexpression cells, NCM460 cells (1 × 10 5 cells/well) were seeded in six-well plates, when 60% confluence was reached, cells were transfected with EphA2 CRISPR activation plasmid or Control CRISPR activation plasmid in antibiotic-free growth medium with UltraCruz ® Transfection Reagent (Santa Cruz, CA, United States) and incubate overnight.

Techniques: Over Expression, Transfection, Clone Assay, Control, Western Blot

EphA2 overexpression abolished the protective effects of ALW-II-41-27 on LPS-induced oxidative stress and inflammation. Effects of EphA2 overexpression on cell viability (A) , LDH leakage (B) , cellular 4-HNE (C) , cellular protein carbonyl (D) , cellular 8-OHdG (E) , cellular HO-1 activity (F) , cellular TNF-α (G) , cellular IL-6 (H) , cellular IL-17 (I) , cellular ICAM-1 (J) , cellular IL-10 (K) and cellular NF-κB activity (L) . ## Indicates a significant difference from control cells ( P < 0.01); ∗ indicates a significant difference from LPS group ( P < 0.05); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Journal: Frontiers in Pharmacology

Article Title: A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways

doi: 10.3389/fphar.2018.00272

Figure Lengend Snippet: EphA2 overexpression abolished the protective effects of ALW-II-41-27 on LPS-induced oxidative stress and inflammation. Effects of EphA2 overexpression on cell viability (A) , LDH leakage (B) , cellular 4-HNE (C) , cellular protein carbonyl (D) , cellular 8-OHdG (E) , cellular HO-1 activity (F) , cellular TNF-α (G) , cellular IL-6 (H) , cellular IL-17 (I) , cellular ICAM-1 (J) , cellular IL-10 (K) and cellular NF-κB activity (L) . ## Indicates a significant difference from control cells ( P < 0.01); ∗ indicates a significant difference from LPS group ( P < 0.05); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Article Snippet: To establish EphA2 gene overexpression cells, NCM460 cells (1 × 10 5 cells/well) were seeded in six-well plates, when 60% confluence was reached, cells were transfected with EphA2 CRISPR activation plasmid or Control CRISPR activation plasmid in antibiotic-free growth medium with UltraCruz ® Transfection Reagent (Santa Cruz, CA, United States) and incubate overnight.

Techniques: Over Expression, Activity Assay, Control

EphA2 knock-out partially inhibited the protective effects of ALW-II-41-27 on LPS-induced oxidative stress and inflammation. Effects of EphA2 knock-out on cell viability (A) , LDH leakage (B) , cellular 4-HNE (C) , cellular protein carbonyl (D) , cellular 8-OHdG (E) , cellular HO-1 activity (F) , cellular TNF-α (G) , cellular IL-6 (H) , cellular IL-17 (I) , cellular ICAM-1 (J) , cellular IL-10 (K) and cellular NF-κB activity (L) . ## Indicates a significant difference from control cells ( P < 0.01); ∗ indicates a significant difference from LPS group ( P < 0.05); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Journal: Frontiers in Pharmacology

Article Title: A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways

doi: 10.3389/fphar.2018.00272

Figure Lengend Snippet: EphA2 knock-out partially inhibited the protective effects of ALW-II-41-27 on LPS-induced oxidative stress and inflammation. Effects of EphA2 knock-out on cell viability (A) , LDH leakage (B) , cellular 4-HNE (C) , cellular protein carbonyl (D) , cellular 8-OHdG (E) , cellular HO-1 activity (F) , cellular TNF-α (G) , cellular IL-6 (H) , cellular IL-17 (I) , cellular ICAM-1 (J) , cellular IL-10 (K) and cellular NF-κB activity (L) . ## Indicates a significant difference from control cells ( P < 0.01); ∗ indicates a significant difference from LPS group ( P < 0.05); ∗∗ indicates a significant difference from LPS group ( P < 0.01); ΔΔ indicates a significant difference from control cells treated LPS; && indicates a significant difference from control cells treated with ALW-II-41-27 and LPS.

Article Snippet: To establish EphA2 gene overexpression cells, NCM460 cells (1 × 10 5 cells/well) were seeded in six-well plates, when 60% confluence was reached, cells were transfected with EphA2 CRISPR activation plasmid or Control CRISPR activation plasmid in antibiotic-free growth medium with UltraCruz ® Transfection Reagent (Santa Cruz, CA, United States) and incubate overnight.

Techniques: Knock-Out, Activity Assay, Control